Andrew P. Bartko
Technology Development
Battelle Memorial Institute
Seminar Information
The need to capture and identify microbial contamination within pharmaceutical production is required to the ensure quality, stability and safety of those products. Current microbial quality control methods are inefficient, increase risk and costly. A spectroscopy-based microbial identification system was developed to improve the manufacturing process and address the production environment monitoring issues. The system performance is discussed in terms of microbial contaminant identification, microbial contaminant quantification of ultra-low concentrations, and contamination trending capability. The microbial identification system utility assessment is described for several pharmaceutical manufacturing sites.
Dr. Andrew P. Bartko received a B.S. from the University of Pittsburgh in 1997 and a Ph.D. in physical chemistry in 2002. His graduate work consisted of deciphering spatially heterogeneous relaxation dynamics of condensed phase systems using novel rotational single molecule microscopy techniques. In 2002, Dr. Bartko joined the Softmatter Nanotechnology and Advanced Spectroscopy Team at Los Alamos National Laboratory where he studied the ultrafast photophysics of semiconducting quantum dots. Dr. Bartko is a Program Leader in Battelle’s Technology Development Group where he directs several applied spectroscopy efforts that focus on biological and chemical sensing. He now leads Battelle’s Rapid, Enumerated, Bioidentification System product and development strategy.